Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This treatment protocol allows doctors to treat advanced kidney cancer with an
investigational drug called sorafenib, BAY43-9006, which is being studied in clinical trials
for kidney cancer and other kinds of cancer. This treatment protocol is not a clinical trial
in which sorafenib is compared to another equal treatment. All patients in this protocol will
be treated with sorafenib. In addition, data from the patients who participate in this
protocol will provide additional information about the drug.